CLDN1 and colitis: Guo et al. reported that inosine intervention alleviates colitis symptoms in mice by modulating NF-κB and Nrf2 pathways, increasing tight junction protein expression (ZO-1, occludin, and claudin-1), and balancing gut microbiota and mitigating colitis.